The new biologics in psoriasis: possible treatments for alopecia areata.
Therapeutics in alopecia areata (AA) have remained relatively unchanged for many years, with few treatments having more than moderate effects in severely affected patients. The advent of the new biologic medications in the dermatologic world, however, particularly in psoriasis treatment, introduces possibilities of treatment for many other immune-mediated diseases.
McMichael
Amy J
AJ
Wake Forest School of Medicine, Winston-Salem, North Carolina 27157-1071, USA. AMCMICHA@WFUBMC.EDU
D000077944:Alefacept; D000506:Alopecia Areata / Q000628:therapy*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D011565:Psoriasis / Q000628:therapy*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; D011993:Recombinant Fusion Proteins; D014409:Tumor Necrosis Factor-alpha; D000077944:Alefacept; C472181:efalizumab